Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (211-220 of 484) with videos related to

Pageof 49
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II StudyChristopher P Denton, Éric Hachulla, Gabriela Riemekasten, et al.
Frontiers in Immunology|February 2, 2023
Dysregulated B cell function and disease pathogenesis in systemic sclerosisClaire F Beesley, Nina R Goldman, Taher E Taher, et al.
Rheumatology (Oxford, England)|July 27, 2021
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosisJulia Spierings, Svetlana I Nihtyanova, Emma Derrett-Smith, et al.
Echocardiography (Mount Kisco, N.Y.)|June 15, 2017
Two-dimensional knowledge-based volumetric reconstruction of the right ventricle documents short-term improvement in pulmonary hypertensionJohannes P Schwaiger, Daniel S Knight, Thomas Kaier, et al.
Arthritis and Rheumatism|July 9, 2003
Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouseVoon H Ong, Lowri A Evans, Xu Shiwen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 5, 2014
Prediction of pulmonary complications and long-term survival in systemic sclerosisSvetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2019
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic SclerosisSvetlana I Nihtyanova, Alper Sari, Jennifer C Harvey, et al.
Arthritis and Rheumatism|March 2, 2011
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosisAriane L Herrick, Frank van den Hoogen, Armando Gabrielli, et al.
Rheumatology (Oxford, England)|June 28, 2015
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosisMichael Hughes, Voon H Ong, Marina E Anderson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
Pageof 49

Showing results (211-220 of 484) with videos related to

Sort By:
Pageof 49
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II StudyChristopher P Denton, Éric Hachulla, Gabriela Riemekasten, et al.
Frontiers in Immunology|February 2, 2023
Dysregulated B cell function and disease pathogenesis in systemic sclerosisClaire F Beesley, Nina R Goldman, Taher E Taher, et al.
Rheumatology (Oxford, England)|July 27, 2021
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosisJulia Spierings, Svetlana I Nihtyanova, Emma Derrett-Smith, et al.
Echocardiography (Mount Kisco, N.Y.)|June 15, 2017
Two-dimensional knowledge-based volumetric reconstruction of the right ventricle documents short-term improvement in pulmonary hypertensionJohannes P Schwaiger, Daniel S Knight, Thomas Kaier, et al.
Arthritis and Rheumatism|July 9, 2003
Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouseVoon H Ong, Lowri A Evans, Xu Shiwen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 5, 2014
Prediction of pulmonary complications and long-term survival in systemic sclerosisSvetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2019
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic SclerosisSvetlana I Nihtyanova, Alper Sari, Jennifer C Harvey, et al.
Arthritis and Rheumatism|March 2, 2011
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosisAriane L Herrick, Frank van den Hoogen, Armando Gabrielli, et al.
Rheumatology (Oxford, England)|June 28, 2015
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosisMichael Hughes, Voon H Ong, Marina E Anderson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
Pageof 49